Literature DB >> 9090345

Reduced morbidity after gradual discontinuation of lithium treatment for bipolar I and II disorders: a replication study.

R J Baldessarini1, L Tondo, G Floris, N Rudas.   

Abstract

OBJECTIVE: The aim of this study was to verify reduction of early affective morbidity by gradual, rather than rapid, discontinuation of lithium treatment.
METHOD: For 78 patients with bipolar disorders, lithium treatment was discontinued either rapidly (over 1-14 days) or gradually (over 15-30 days). The effects of the two schedules were compared by survival analysis of time to first recurrence.
RESULTS: Median time to recurrence was 5.6 times as long for gradual discontinuation (14.0 months) as for rapid discontinuation (2.5 months). The ratios of the median survival times for gradual and rapid discontinuation were similar in I and II subtypes and in depression and mania (4-6:1). The polarities of the episodes at onset and at first recurrence after lithium discontinuation were 83.6% concordant.
CONCLUSIONS: These results independently confirm a reduction in morbid risk from slow discontinuation of lithium treatment for bipolar disorders.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9090345     DOI: 10.1176/ajp.154.4.551

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  11 in total

1.  BALANCE: a large simple trial of maintenance treatment for bipolar disorder.

Authors:  John R Geddes; Jennifer M Rendell; Guy M Goodwin
Journal:  World Psychiatry       Date:  2002-02       Impact factor: 49.548

2.  Discontinuing treatment for psychiatric disorders.

Authors:  Russell T Joffe
Journal:  J Psychiatry Neurosci       Date:  2006-01       Impact factor: 6.186

3.  If devolved facilities are used, processes may be streamlined

Authors: 
Journal:  BMJ       Date:  1998-09-19

4.  Lithium. Still effective despite its detractors.

Authors:  J W Jefferson
Journal:  BMJ       Date:  1998-05-02

5.  Lithium for the Maintenance Treatment of Bipolar I Disorder: A Double-Blind, Placebo-Controlled Discontinuation Study.

Authors:  Robert L Findling; Nora K McNamara; Mani Pavuluri; Jean A Frazier; Moira Rynn; Russell Scheffer; Vivian Kafantaris; Adelaide Robb; Melissa DelBello; Robert A Kowatch; Brieana M Rowles; Jacqui Lingler; Jian Zhao; Traci Clemons; Karen Martz; Ravinder Anand; Perdita Taylor-Zapata
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2018-11-26       Impact factor: 8.829

Review 6.  The ability of lithium and other mood stabilizers to decrease suicide risk and prevent relapse.

Authors:  C L Bowden
Journal:  Curr Psychiatry Rep       Date:  2000-12       Impact factor: 5.285

7.  Bipolar disorder.

Authors:  F K Goodwin; S N Ghaemi
Journal:  Dialogues Clin Neurosci       Date:  1999-06       Impact factor: 5.986

8.  Does the "Silver Bullet" Lose its Shine Over the Time? Assessment of Loss of Lithium Response in a Preliminary Sample of Bipolar Disorder Outpatients.

Authors:  M Fornaro; B Stubbs; D De Berardis; F Iasevoli; M Solmi; N Veronese; A Carano; G Perna; A De Bartolomeis
Journal:  Clin Pract Epidemiol Ment Health       Date:  2016-12-23

9.  Discontinuing psychotropic drug treatment.

Authors:  Leonardo Tondo; Ross J Baldessarini
Journal:  BJPsych Open       Date:  2020-02-19

10.  Recurrence risk in bipolar manic-depressive disorders after discontinuing lithium maintenance treatment: an overview.

Authors:  R J Baldessarini; L Tondo
Journal:  Clin Drug Investig       Date:  1998       Impact factor: 3.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.